Feasibility and Efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children With Congenital Heart Disease (NEURODEV-IPA)

University Hospital Center (CHU)

Status

Enrolling

Conditions

Neurodevelopmental Disorders

Congenital Heart Disease in Children

Treatments

Other: Screening for neurodevelopmental disorders by an advanced practice nurse

Study type

Interventional

Funder types

Other

Identifiers

NCT06431269

RECHMPL21_0291

ID-RCB (Other Identifier)

Details and patient eligibility

About

Feasibility and efficiency of Screening for Neurodevelopmental Disorders by an Advanced Practice Nurse in Children aged 1 to 5 with Congenital Heart Disease

Full description

Congenital heart disease (CHD) is the leading cause of birth defects. Over 90% of children born with CHD reach adulthood. 50% of them will develop a neurodevelopmental disorder (NDD) that could affect life and long-term prognosis, including scholar and social integration and health related quality of life.

In France, there is a lack of medical resources to screen NDD in this population and to refer patients for appropriate and early treatment.

Investigators plan to propose a systematic early screening of NDD by an Advanced Practice Nurse (APN) during the usual cardiac follow-up. Children with CHD aged 1 to 5 will be included. If NDD is suspected, the patient will be referred to a neuropsychologist for NDD diagnosis confirmation and management planning. Patients with higher NDD risks (neonatal cardiac surgery) will benefit from a systematic neuropsychologist evaluation.

This study will investigate the feasibility and performance of an APN screening in this NDD-high risk population.

Enrollment

270 estimated patients

Sex

All

Ages

1 to 5 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Congenital heart disease with stable status defined by last operation >3 months, no cardiac decompensation in the last 3 months, no planned surgery within 6 months after the inclusion
Cardiac surgery and/or catheter-based cardiac intervention(s) during the first year of life,
Patient aged 1 to 5 years.
No previous medical diagnosis of NDD
Parental or legal guardian's consent.
Social security affiliation (for France only)

Exclusion criteria

Patients with a genetic or poly-malformative syndrome with known neurological impairment.
Neurodevelopmental disorder already known/treated
Neurodevelopmental status evaluation within the last 6 months.